已收录 268921 条政策
 政策提纲
  • 暂无提纲
The Use of Botulinum Neurotoxin Type A in a Patient With Refractory Urge Incontinence to Facilitate the Intravesical Treatment of Bladder Carcinoma
[摘要] Intravesical Bacillus Calmette-Guérin (BCG) has become the preferred initial treatment after resection of high-grade T1 urothelial carcinoma and carcinoma in situ (CIS). We report the case of a patient with high-grade T1 urothelial carcinoma and CIS who was treated with intravesical BCG. Due to the patient’s severe urge incontinence, however, the BCG solution leaked from the bladder immediately upon instillation. We describe our experience of using botulinum neurotoxin A intradetrusor injections to facilitate successful intravesical therapy by increasing bladder capacity to enable the BCG to remain in the patient’s bladder for the appropriate treatment duration.
[发布日期]  [发布机构] 
[效力级别]  [学科分类] 基础医学
[关键词] Bacillus Calmette-Guérin;Bladder carcinoma;Botulinum neurotoxin;Gemcitabine;Urge incontinence [时效性] 
   浏览次数:15      统一登录查看全文      激活码登录查看全文